Cite

HARVARD Citation

    Ma, W. et al. (2019). Bichromophoric anticancer drug: Targeting lysosome with rhodamine modified cyclometalated Iridium(III) complexes. Dyes and pigments. pp. 385-393. [Online]. 
  
Back to record